Some recent FDA approvals have made many people aware of tumor-agnostic treatments. But what does that mean and how could it benefit someone with cancer? ASCO Chief Medical Officer Richard L. Schilsky gives insight into this new way of thinking about cancer treatment. Read More >>
targeted therapy
December 20, 2018 · Richard L. Schilsky, MD, FACP, FSCT, FASCO
November 8, 2018 · Brian I. Rini, MD
Kidney cancer is the sixth most common cancer for men and the tenth most common cancer for women. Cancer.Net Associate Editor Brian Rini, MD, shares 4 things people need to know about kidney cancer. Read More >>
June 14, 2018 · Jyoti Patel, MD, FASCO
Lung cancer affects tens of thousands of Americans every year. In this blog post, Cancer.Net Associate Editor Dr. Jyoti Patel describes 9 things every person should know about lung cancer. Read More >>
February 14, 2018 · Greg Guthrie, ASCO staff
In this podcast, Dr. Gary Lyman describes biosimilars for cancer treatment and why they are important. He also talks about why ASCO is releasing a statement on them today. Read More >>
September 15, 2016 · Himisha Beltran, MD
Identifying genetic changes has given us new insights in early detection and treatment of advanced and castration-resistant prostate cancer. Read More >>